Answers are grounded in this paper and cite their sources.
The current study focuses on the emerging idea of naturally occuring, chalcone-based inhibitors that will prevent angiogenic switching (fibroblast growth factor angiogenin, TGF-), which is prevented by directly inhibiting vascular endothelial growth factor receptor-2 (VEGFR-2), which prevents neovascularization, vascular formation, and network formation. The presented papers will encourage future researchers, pharmaceutical scientists, aspirant investigators, and related specialists to develop or look at potential angiogenic inhibitors.
No takes yet. Share an insight, caveat, or question.
Kamini Kashyap (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: